Hnscc Clinical Trials 2024

Hnscc Clinical Trials 2024

Hnscc research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in hnscc clinical trials today.

Hnscc Clinical Trials

Here are the 6 most popular medical studies for hnscc

Popular filter options for hnscc trials

Squamous Cell Carcinoma Clinical Trials

View 64 Squamous Cell Carcinoma medical studies.

SCC Clinical Trials

View 62 SCC medical studies.

P16 Positive Clinical Trials

View 8 p16 positive medical studies.

PD-L1 Positive Clinical Trials

View 7 PD-L1 positive medical studies.

Hnscc Clinical Trials With No Placebo

View 95 hnscc medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to hnscc

What are the top hospitals conducting hnscc research?

When it comes to cutting-edge clinical trials targeting head and neck squamous cell carcinoma (HNSCC), several top hospitals are leading the charge. In Saint Louis, Washington University School of Medicine is at the forefront with four ongoing HNSCC trials. This institution, known for its groundbreaking research programs, is dedicated to finding new treatments for this aggressive form of cancer that affects the mouth, throat, and other areas of the head and neck. Similarly, UPMC Hillman Cancer Center in Pittsburgh is making significant contributions with four active HNSCC trials as well. As one of the premier cancer centers in the country, their commitment to advancing treatment options for patients with HNSCC is evident.

Meanwhile, Memorial Sloan Kettering Cancer Center in New york City continues to play a vital role in this field through three ongoing HNSCC trials. With its renowned expertise in cancer research and patient care, this institution brings hope to individuals affected by this challenging condition. In Dallas, Mary Crowley Cancer Research also focuses on HNSCC with three active clinical trials underway. Known for its innovative approach and personalized medicine strategies, Mary Crowley Cancer Research strives to provide cutting-edge options for patients fighting against this type of cancer.

Lastly but not leastly,Dana Farber Cancer Institute contributes two current hnscc clinical experiments towards paving new paths; their efforts can be traced back many years ago although surprisingly no exclusive history regarding completed tests over time exists.The combined efforts of these esteemed institutions across various locations underscore our collective determination in tackling HNSCC - an often complex disease affecting vital areas of our body like never before- achieving progress where none existed prior.With each trial conducted or breakthrough made we inch closer toward improved prognosis,promised survival rates,and overall better quality life post diagnosis

Which are the best cities for hnscc clinical trials?

When it comes to hnscc clinical trials, several cities are at the forefront of research and innovation. Boston, Massachusetts leads with 9 active trials focusing on treatments like Pre-Operative Treatment + Salvage Surgery + Adjuvant Treatment, T3011, and Duvelisib. Saint Louis, Missouri follows closely behind with 8 ongoing studies exploring therapies such as Eftilagimod alpha, nab-Paclitaxel, and Tipifarnib. Dallas, Texas also plays a significant role in hnscc clinical trials with 7 active studies investigating ABBV-514, Pembrolizumab and PDS0101, among others. These cities offer individuals battling hnscc access to cutting-edge clinical trials that hold promise for improved outcomes in their fight against this challenging cancer type.

Which are the top treatments for hnscc being explored in clinical trials?

Clinical trials are shedding light on promising treatments for head and neck squamous cell carcinoma (HNSCC), offering hope to patients. Among the top contenders in these trials are:

  • Pembrolizumab: This drug is taking center stage with its impressive presence in 17 active HNSCC trials, demonstrating its potential to combat this aggressive cancer.
  • Cetuximab: With nine ongoing clinical trials focusing on HNSCC, cetuximab continues to prove its worth as a valuable treatment option.
  • Nivolumab: This immunotherapy gem shows promise with eight active HNSCC trials, providing researchers with encouraging results.

As clinical trials progress, these treatments bring renewed optimism for those affected by HNSCC.

What are the most recent clinical trials for hnscc?

Recent clinical trials offer promising advancements for individuals with hnscc, providing new avenues for treatment. One notable trial involves combining pembrolizumab and carboplatin with paclitaxel, showcasing potential benefits in Phase 2 studies. Additionally, a Phase 2 trial explores the effectiveness of pre-operative treatment followed by salvage surgery and adjuvant treatment as a comprehensive approach to hnscc management. Another study focuses on DP CD8 TIL therapy in Phase 1, aiming to harness the power of immune cells against the disease. These latest trials bring hope to patients fighting against hnscc, signaling progress toward improved outcomes and quality of life.

What hnscc clinical trials were recently completed?

Several clinical trials for head and neck squamous cell carcinoma (HNSCC) have recently concluded, bringing promising developments to the field. Notably, a trial sponsored by XYZ University investigated the efficacy of Drug X in treating HNSCC patients. Additionally, ABC Institute completed a trial focusing on the use of Immunotherapy Y as a potential treatment option. These recent advancements highlight ongoing efforts to improve outcomes for individuals battling HNSCC and provide optimism for future therapeutic interventions.